BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lawsuit Against Synthes, Inc. (SYST) in Unapproved Trials Deaths


3/2/2012 8:53:10 AM

Medical device company Synthes and former executives have been sued in California over the deaths of two patients who, according to the lawsuit, died after clinical trials of a Synthes bone cement product that were not approved by the Food and Drug Administration, the Philadelphia Inquirer reports.

Synthes executives were sentenced to prison terms late last year over charges related to the case.

The edlerly patients "died after their blood pressure dropped precipitously and doctors could not revive them, though the bone cement could not be definitively identified as the cause of death," the Inquirer said.

Synthes, which has its U.S. headquarters in West Chester, Pa., has agreed to be sold to Johnson & Johnson (NYSE:JNJ).




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES